Stress-related genes and heroin addiction: A role for a functional FKBP5 haplotype

Psychoneuroendocrinology

Volumn 45, Issue , 2014, Pages 67-76

  Levran, O ^a   Peles, E ^b,c   Randesi, M ^a   Li, Y ^d   Rotrosen, J ^e   Ott, J ^a,f   Adelson, M ^a,b,g   Kreek, M J ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d SHANXI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f INSTITUTE OF PSYCHOLOGY   (China)

^g Dr Miriam and Sheldon G Adelson Clinic for Drug Abuse Treatment and Research   (United States)

Author keywords

Association study; AVPR1A; FKBP5; GAL; Genetic variants; Glucocorticoid sensitivity; Heroin addiction; HPA axis; Stress

Indexed keywords

DIAMORPHINE; METHADONE; FK 506 BINDING PROTEIN; TACROLIMUS BINDING PROTEIN 5;

3' UNTRANSLATED REGION; ADULT; AFRICAN AMERICAN; ARTICLE; AVP GENE; AVPR1A GENE; CONTROLLED STUDY; CRHR1 GENE; CRHR2 GENE; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; FKBP5 GENE; GAL GENE; GENE; GENE EXPRESSION; GENOTYPE; GLRA1 GENE; HAPLOTYPE; HEROIN DEPENDENCE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NPY1R GENE; NR3C2 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; STRESS RELATED GENE; CASE CONTROL STUDY; EPIDEMIOLOGY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; MIDDLE AGED; PHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HEROIN DEPENDENCE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS, PSYCHOLOGICAL; TACROLIMUS BINDING PROTEINS;

EID: 84901228074     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.03.017     Document Type: Article

References (59)

1. Appel K., Schwahn C., Mahler J., Schulz A., Spitzer C., Fenske K., Stender J., Barnow S., John U., Teumer A., Biffar R., Nauck M., Volzke H., Freyberger H.J., Grabe H.J. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 2011, 36:1982-1991.
2. Atzmon G., Hao L., Pe'er I., Velez C., Pearlman A., Palamara P.F., Morrow B., Friedman E., Oddoux C., Burns E., Ostrer H. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. Am. J. Hum. Genet. 2010, 86:850-859.
3. Belfer I., Hipp H., McKnight C., Evans C., Buzas B., Bollettino A., Albaugh B., Virkkunen M., Yuan Q., Max M.B., Goldman D., Enoch M.A. Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol. Psychiatry 2006, 11:301-311.
4. Bevilacqua L., Carli V., Sarchiapone M., George D.K., Goldman D., Roy A., Enoch M.A. Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch. Gen. Psychiatry 2012, 69:62-70.
5. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
6. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., Tang Y., Gillespie C.F., Heim C.M., Nemeroff C.B., Schwartz A.C., Cubells J.F., Ressler K.J. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
7. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., Papiol S., Seaman S., Lucae S., Kohli M.A., Nickel T., Kunzel H.E., Fuchs B., Majer M., Pfennig A., Kern N., Brunner J., Modell S., Baghai T., Deiml T., Zill P., Bondy B., Rupprecht R., Messer T., Kohnlein O., Dabitz H., Bruckl T., Muller N., Pfister H., Lieb R., Mueller J.C., Lohmussaar E., Strom T.M., Bettecken T., Meitinger T., Uhr M., Rein T., Holsboer F., Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004, 36:1319-1325.
8. Boscarino J.A., Erlich P.M., Hoffman S.N., Zhang X. Higher FKBP5, COMT, CHRNA5, and CRHR1 allele burdens are associated with PTSD and interact with trauma exposure: implications for neuropsychiatric research and treatment. Neuropsychiatr. Dis. Treat. 2012, 8:131-139.
9. Domschke K., Reif A. Behavioral genetics of affective and anxiety disorders. Curr. Top. Behav. Neurosci. 2012, 12:463-502.
10. Ducci F., Roy A., Shen P.H., Yuan Q., Yuan N.P., Hodgkinson C.A., Goldman L.R., Goldman D. Association of substance use disorders with childhood trauma but not African genetic heritage in an African American cohort. Am. J. Psychiatry 2009, 166:1031-1040.
11. Duggal P., Gillanders E.M., Holmes T.N., Bailey-Wilson J.E. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics 2008, 9:516.
12. Engineer N., Darwin L., Nishigandh D., Ngianga-Bakwin K., Smith S.C., Grammatopoulos D.K. Association of glucocorticoid and type 1 corticotropin-releasing hormone receptors gene variants and risk for depression during pregnancy and post-partum. J. Psychiatr. Res. 2013, 47:1166-1173.
13. Fani N., Gutman D., Tone E.B., Almli L., Mercer K.B., Davis J., Glover E., Jovanovic T., Bradley B., Dinov I.D., Zamanyan A., Toga A.W., Binder E.B., Ressler K.J. FKBP5 and attention bias for threat: associations with hippocampal function and shape. JAMA Psychiatry 2013, 70:392-400.
14. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
15. Galigniana N.M., Ballmer L.T., Toneatto J., Erlejman A.G., Lagadari M., Galigniana M.D. Regulation of the glucocorticoid response to stress-related disorders by the Hsp90-binding immunophilin FKBP51. J. Neurochem. 2012, 122:4-18.
16. Hartmann J., Wagner K.V., Liebl C., Scharf S.H., Wang X.D., Wolf M., Hausch F., Rein T., Schmidt U., Touma C., Cheung-Flynn J., Cox M.B., Smith D.F., Holsboer F., Muller M.B., Schmidt M.V. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 2012, 62:332-339.
17. Hassan H.E., Myers A.L., Lee I.J., Chen H., Coop A., Eddington N.D. Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis. Drug Metab. Dispos. 2010, 38:157-167.
18. Hodgkinson C.A., Yuan Q., Xu K., Shen P.H., Heinz E., Lobos E.A., Binder E.B., Cubells J., Ehlers C.L., Gelernter J., Mann J., Riley B., Roy A., Tabakoff B., Todd R.D., Zhou Z., Goldman D. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008, 43:505-515.
19. Homayoun H., Khavandgar S., Mehr S.E., Namiranian K., Dehpour A.R. The effects of FK506 on the development and expression of morphine tolerance and dependence in mice. Behav. Pharmacol. 2003, 14:121-127.
20. Kellogg S.H., McHugh P.F., Bell K., Schluger J.H., Schluger R.P., LaForge K.S., Ho A., Kreek M.J. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend. 2003, 69:137-150.
21. Klengel T., Mehta D., Anacker C., Rex-Haffner M., Pruessner J.C., Pariante C.M., Pace T.W., Mercer K.B., Mayberg H.S., Bradley B., Nemeroff C.B., Holsboer F., Heim C.M., Ressler K.J., Rein T., Binder E.B. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 2013, 16:33-41.
22. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am. J. Psychiatry 2007, 164:1149-1159.
23. Koob G.F. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 2010, 1314:3-14.
24. Kreek M.J., Levran O., Reed B., Schlussman S.D., Zhou Y., Butelman E.R. Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J. Clin. Invest. 2012, 122:3387-3393.
25. Kreek M.J., Nielsen D.A., Butelman E.R., LaForge K.S. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 2005, 8:1450-1457.
26. Lee R.S., Tamashiro K.L., Yang X., Purcell R.H., Huo Y., Rongione M., Potash J.B., Wand G.S. A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl) 2011, 218:303-312.
27. Levran O., Londono D., O'Hara K., Nielsen D.A., Peles E., Rotrosen J., Casadonte P., Linzy S., Randesi M., Ott J., Adelson M., Kreek M.J. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behavior 2008, 7:720-729.
28. Levran O., Londono D., O'Hara K., Randesi M., Rotrosen J., Casadonte P., Linzy S., Ott J., Adelson M., Kreek M.J. Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behavior 2009, 8:531-540.
29. Liu H.X., Chew S.L., Cartegni L., Zhang M.Q., Krainer A.R. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol. Cell. Biol. 2000, 20:1063-1071.
30. Liu Z., Liu W., Yao L., Yang C., Xiao L., Wan Q., Gao K., Wang H., Zhu F., Wang G., Xiao Z. Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. Sci. Rep. 2013, 3:1548.
31. Liu Z., Zhu F., Wang G., Xiao Z., Wang H., Tang J., Wang X., Qiu D., Liu W., Cao Z., Li W. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci. Lett. 2006, 404:358-362.
32. Maher B.S., Vladimirov V.I., Latendresse S.J., Thiselton D.L., McNamee R., Kang M., Bigdeli T.B., Chen X., Riley B.P., Hettema J.M., Chilcoat H., Heidbreder C., Muglia P., Murrelle E.L., Dick D.M., Aliev F., Agrawal A., Edenberg H.J., Kramer J., Nurnberger J., Tischfield J.A., Devlin B., Ferrell R.E., Kirillova G.P., Tarter R.E., Kendler K.S., Vanyukov M.M. The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol. Psychiatry 2011, 70:519-527.
33. Mahon P.B., Zandi P.P., Potash J.B., Nestadt G., Wand G.S. Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults. Psychopharmacology (Berl) 2013, 227:231-241.
34. Mantel N. Assessing laboratory evidence for neoplastic activity. Biometrics 1980, 36:381-399.
35. McClung C.A., Nestler E.J., Zachariou V. Regulation of gene expression by chronic morphine and morphine withdrawal in the locus ceruleus and ventral tegmental area. J. Neurosci. 2005, 25:6005-6015.
36. McEwen B.S., Gianaros P.J. Stress- and allostasis-induced brain plasticity. Annu. Rev. Med. 2011, 62:431-445.
37. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 1992, 9:199-213.
38. Menke A., Klengel T., Rubel J., Bruckl T., Pfister H., Lucae S., Uhr M., Holsboer F., Binder E.B. Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behavior 2013, 12:289-296.
39. Mills K.L., Lynskey M., Teesson M., Ross J., Darke S. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Depend. 2005, 77:243-249.
40. Nelson E.C., Heath A.C., Lynskey M.T., Bucholz K.K., Madden P.A., Statham D.J., Martin N.G. Childhood sexual abuse and risks for licit and illicit drug-related outcomes: a twin study. Psychol. Med. 2006, 36:1473-1483.
41. Nossent A.Y., Hansen J.L., Doggen C., Quax P.H., Sheikh S.P., Rosendaal F.R. SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am. J. Hypertens. 2011, 24:999-1006.
42. Piechota M., Korostynski M., Sikora M., Golda S., Dzbek J., Przewlocki R. Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine. Genes Brain Behavior 2012, 11:404-414.
43. Proudnikov D., Hamon S., Ott J., Kreek M.J. Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction. Neurosci. Lett. 2008, 435:234-239.
44. Roy A., Gorodetsky E., Yuan Q., Goldman D., Enoch M.A. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010, 35:1674-1683.
45. Roy A., Hodgkinson C.A., Deluca V., Goldman D., Enoch M.A. Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J. Psychiatr. Res. 2012, 46:72-79.
46. Sansone R.A., Whitecar P., Wiederman M.W. The prevalence of childhood trauma among those seeking buprenorphine treatment. J. Addict. Dis. 2009, 28:64-67.
47. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. N.Y. Acad. Sci. 2008, 1141:105-130.
48. Stephens M.A., Wand G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res. 2012, 34:468-483.
49. Tian C., Kosoy R., Nassir R., Lee A., Villoslada P., Klareskog L., Hammarstrom L., Garchon H.J., Pulver A.E., Ransom M., Gregersen P.K., Seldin M.F. European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol. Med. 2009, 15:371-383.
50. Touma C., Gassen N.C., Herrmann L., Cheung-Flynn J., Bull D.R., Ionescu I.A., Heinzmann J.M., Knapman A., Siebertz A., Depping A.M., Hartmann J., Hausch F., Schmidt M.V., Holsboer F., Ising M., Cox M.B., Schmidt U., Rein T. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 2011, 70:928-936.
51. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 2009, 10:397-409.
52. Velders F.P., Kuningas M., Kumari M., Dekker M.J., Uitterlinden A.G., Kirschbaum C., Hek K., Hofman A., Verhulst F.C., Kivimaki M., Van Duijn C.M., Walker B.R., Tiemeier H. Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology 2011, 36:1053-1061.
53. Wang Y.J., Li H., Yang Y.T., Tie C.L., Li F., Xu Z.Q., Wang C.Y. Association of galanin and major depressive disorder in the Chinese Han population. PLoS ONE 2013, 8:e64617.
54. Wei J., Chu C., Wang Y., Yang Y., Wang Q., Li T., Zhang L., Ma X. Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict. Behav. 2012, 37:622-626.
55. Wetherill L., Schuckit M.A., Hesselbrock V., Xuei X., Liang T., Dick D.M., Kramer J., Nurnberger J.I., Tischfield J.A., Porjesz B., Edenberg H.J., Foroud T. Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcoholism. Clin. Exp. Res. 2008, 32:2031-2040.
56. Willour V.L., Chen H., Toolan J., Belmonte P., Cutler D.J., Goes F.S., Zandi P.P., Lee R.S., MacKinnon D.F., Mondimore F.M., Schweizer B., Bipolar Disorder Phenome G., Consortium N.G.I.B.D., DePaulo J.R., Gershon E.S., McMahon F.J., Potash J.B. Family-based association of FKBP5 in bipolar disorder. Mol. Psychiatry 2009, 14:261-268.
57. Xiao Z., Liu W., Gao K., Wan Q., Yang C., Wang H., Wang X., Wang G., Liu Z. Interaction between CRHR1 and BDNF genes increases the risk of recurrent major depressive disorder in Chinese population. PLoS ONE 2011, 6:e28733.
58. Xie P., Kranzler H.R., Poling J., Stein M.B., Anton R.F., Farrer L.A., Gelernter J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010, 35:1684-1692.
59. Yang X., Ewald E.R., Huo Y., Tamashiro K.L., Salvatori R., Sawa A., Wand G.S., Lee R.S. Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5. Biochem. Biophys. Res. Commun. 2012, 420:570-575.